(Q38142595)

29 August 2017

title

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa (English)

1 reference

29 August 2017

1 reference

M A Ingersoll

1

1 reference

29 August 2017

M L Albert

series ordinal

2

1 reference

29 August 2017

language of work or name

1 reference

25 September 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

6

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

1041-1053

1 reference

Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

The mammalian urinary bladder: an accommodating organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Uroplakins in urothelial biology, function, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Antimicrobial peptides, innate immunity, and the normally sterile urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Viable but nonculturable bacteria are present in mouse and human urine specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Viable but nonculturable uropathogenic bacteria are present in the mouse urinary tract following urinary tract infection and antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Characterization of microbial communities found in the human vagina by analysis of terminal restriction fragment length polymorphisms of 16S rRNA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Vaginal microbiome of reproductive-age women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Bacterial adhesion to target cells enhanced by shear force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

The mechanical properties of E. coli type 1 pili measured by atomic force microscopy techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

The shaft of the type 1 fimbriae regulates an external force to match the FimH catch bond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Role of surface mucin in primary antibacterial defense of bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Characterization of the mouse beta defensin 1, Defb1, mutant mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Human alpha defensin 5 expression in the human kidney and urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Human beta-defensin-1: an antimicrobial peptide of urogenital tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

The immune geography of IgA induction and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Anti-Ia-reactive cells in the urinary tract of man, guinea-pig, rat and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

CCR2 mediates homeostatic and inflammatory release of Gr1(high) monocytes from the bone marrow, but is dispensable for bladder infiltration in bacterial urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Deciphering the transcriptional network of the dendritic cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Diagnosis and treatment of uncomplicated urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

The etiology of urinary tract infection: traditional and emerging pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Type 1 pilus-mediated bacterial invasion of bladder epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Bacterial penetration of bladder epithelium through lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Dynamin2- and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Intracellular bacterial biofilm-like pods in urinary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Detection of intracellular bacterial communities in human urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Enterococcus faecalis tropism for the kidneys in the urinary tract of C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Characterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Microbial biofilm formation and catheter-associated bacteriuria in patients with suprapubic catheterisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Proteus mirabilis biofilms and catheter-associated urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Host-pathogen interactions in urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Diversity of group B streptococcus serotypes causing urinary tract infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Neutrophil recruitment and resistance to urinary tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Association of Toll-like receptor 4 gene polymorphism and expression with urinary tract infection types in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Innate and adaptive immune responses in the urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

A toll-like receptor that prevents infection by uropathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Uropathogenic E. coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Urinary interleukin-6 and interleukin-8 in children with urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Mast cell interleukin-10 drives localized tolerance in chronic bladder infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Urinary Tract Infections in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Simplified quantitative methods for bacteriuria and pyuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Monocyte trafficking in acute and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Early Severe Inflammatory Responses to Uropathogenic E. coli Predispose to Chronic and Recurrent Urinary Tract Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Mucosal immunization with iron receptor antigens protects against urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Waging war against uropathogenic Escherichia coli: winning back the urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Bacteria-induced uroplakin signaling mediates bladder response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Epidemiology of urinary tract infections: incidence, morbidity, and economic costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Bacterial interference--is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Urinary tract infections in the elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Identification of genes important for growth of asymptomatic bacteriuria Escherichia coli in urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

A prospective study of asymptomatic bacteriuria in sexually active young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Host imprints on bacterial genomes--rapid, divergent evolution in individual patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Genetic control of the variable innate immune response to asymptomatic bacteriuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Estimates of the cancer incidence and mortality in Europe in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Urothelial tumorigenesis: a tale of divergent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Inactivation of p53 and Pten promotes invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Role of neutrophils in BCG immunotherapy for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Cytokine Gene Expression in a Mouse Model: The First Instillations With Viable bacillus Calmette-Guerin Determine the Succeeding Th1 Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Monitoring high-risk bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Cytokine gene polymorphisms can alter the effect of Bacillus Calmette-Guérin (BCG) immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Effects of intravesical liposome-mediated human beta-defensin-2 gene transfection in a mouse urinary tract infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Treatment and prevention of urinary tract infection with orally active FimH inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Bacillus Calmette-Guérin with or without interferon α-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Distinct Glycan Structures of Uroplakins Ia and Ib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Acute Uncomplicated Cystitis in an Era of Increasing Antibiotic Resistance: A Proposed Approach to Empirical Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

The Bacterial Flora of the Vaginal Vestibule, Urethra and Vagina in the Normal Premenopausal Woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Bladder surface glycosaminoglycans: an epithelial permeability barrier

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Effect of ammonium on bacterial adherence to bladder transitional epithelium

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Impairment of antibacterial effect of bladder surface mucin by protamine sulfate

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Reversible inactivation of bladder surface glycosaminoglycan antibacterial activity by protamine sulfate

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Enhancement of Bacillus Calmette-Guerin Attachment to the Urothelium by Removal of the Rabbit Bladder Mucin Layer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

THE BLADDER DOES NOT APPEAR TO HAVE A DYNAMIC SECRETED CONTINUOUS MUCOUS GEL LAYER

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Does low urinary sIgA predispose to urinary tract infection?

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Structural analysis of human beta-defensin-1 and its significance in urinary tract infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Immunohistochemical analysis of the human bladder

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Candida urinary tract infections--epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Escherichia coli induces transuroepithelial neutrophil migration by an intercellular adhesion molecule-1-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Congenital immunodeficiencies in mice increase susceptibility to urinary tract infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Immunization against urinary tract infection with a multi-valent vaginal vaccine

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Bacterial interference for prevention of urinary tract infection: an overview

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Editorial commentary: asymptomatic bacteriuria--shift of paradigm

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Interleukin-8 and CXCR1 Receptor Functional Polymorphisms and Susceptibility to Acute Pyelonephritis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Internalization of bacille Calmette-Guerin by bladder tumor cells.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Prognostic value of tumor-associated macrophage count in human bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Requirement of a thymus dependent immune response for BCG-mediated antitumor activity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

NK cells are essential for effective BCG immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Urinary IL‐2 assay for monitoring intravesical bacillus Calmette‐Guérin response of superficial bladder cancer during induction course and maintenance therapy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Bacille Calmette-Guérin in superficial transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Antitumour immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Bacillus Calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.72

7 January 2021

Identifiers

DOI

10.1038/MI.2013.72

1 reference

Dimensions Publication ID

29 August 2017

1030524243

0 references

1 reference